155 related articles for article (PubMed ID: 28109113)
1. [Effect of sodium phenylbutyrate on the sensitivity of PC3/DTX-resistant prostate cancer cells to docetaxel].
Xu YW; Zheng SB; Chen BS; Wen Y; Zhu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Novemer 20; 37(1):130-134. PubMed ID: 28109113
[TBL] [Abstract][Full Text] [Related]
2. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
Festuccia C; Gravina GL; D'Alessandro AM; Muzi P; Millimaggi D; Dolo V; Ricevuto E; Vicentini C; Bologna M
Endocr Relat Cancer; 2009 Jun; 16(2):401-13. PubMed ID: 19153211
[TBL] [Abstract][Full Text] [Related]
3. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells.
Shi GH; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Xiao WJ; Ma CG
Acta Pharmacol Sin; 2010 Jul; 31(7):867-73. PubMed ID: 20581857
[TBL] [Abstract][Full Text] [Related]
5. [2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel].
Zhou P; Lin YR; Huang MP; Xie KJ; Tang P
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3230-4. PubMed ID: 24405548
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
[TBL] [Abstract][Full Text] [Related]
7. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
[TBL] [Abstract][Full Text] [Related]
8. [Effect of sodium phenylbutyrate on the apoptosis of human tongue squamous cancer cell line and expression of p21 and survivin genes].
Chen WQ; Feng FL; Gu HB; Pan DS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Jul; 45(7):416-20. PubMed ID: 21122434
[TBL] [Abstract][Full Text] [Related]
9. Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line.
Cancino-Marentes ME; Hernández-Flores G; Ortiz-Lazareno PC; Villaseñor-García MM; Orozco-Alonso E; Sierra-Díaz E; Solís-Martínez RA; Cruz-Gálvez CC; Bravo-Cuellar A
BMC Urol; 2021 Mar; 21(1):38. PubMed ID: 33711972
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.
Jorfi S; Ansa-Addo EA; Kholia S; Stratton D; Valley S; Lange S; Inal J
Sci Rep; 2015 Aug; 5():13006. PubMed ID: 26302712
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
Liu H; Song X; Hou J; Zhao Z; Chang J
DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
[TBL] [Abstract][Full Text] [Related]
12. Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells.
Inamura SO; Ito H; Taga M; Tsuchiyama K; Hoshino H; Kobayashi M; Yokoyama O
Anticancer Res; 2019 Oct; 39(10):5417-5425. PubMed ID: 31570436
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
Watanabe H; Kawakami A; Sato R; Watanabe K; Matsushita Y; Miyake H
Anticancer Res; 2021 Aug; 41(8):3753-3758. PubMed ID: 34281834
[TBL] [Abstract][Full Text] [Related]
14. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
[TBL] [Abstract][Full Text] [Related]
16. Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer.
Lin F; Wen D; Wang X; Mahato RI
Biomaterials; 2019 Feb; 192():95-108. PubMed ID: 30447399
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
19. Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration.
Xu Y; Zheng S; Chen B; Wen Y; Zhu S
Onco Targets Ther; 2016; 9():2825-33. PubMed ID: 27274278
[TBL] [Abstract][Full Text] [Related]
20. Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
Shen Y; Ma Z; Chen F; Dong Q; Hu Q; Bai L; Chen J
J Drug Target; 2015; 23(6):568-76. PubMed ID: 25738990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
